The follow-up of the effect of the therapy of a medicinal product/extended therapeutic indications, for which it has not yet been paid for in the relevant PLS application, is carried out for a period until the initial maintenance of the reimbursement status of the medicinal product. If during the assessment of the effect of the therapy it is established that such cannot be performed on the basis of the collected data, or the assessment does not have sufficient statistical reliability, then while maintaining the reimbursement status, the Council may decide that the follow-up of the effect of the therapy should continue for period until the next maintenance of the reimbursement status of the medicinal product. In this case, the Council may amend and/or supplement the conditions and criteria for monitoring the effect of therapy with medicinal products, as well as the therapeutic indications to be monitored. The monitoring of the effect of the therapy of a medicinal product, which is a comparative alternative to a medicinal product designated for monitoring, or of a medicinal product in which there is a need to perform an analysis of the effective and appropriate spending of public funds by the relevant paying institution, is carried out for a period of 1 to 3 years depending on the therapeutic scheme of the respective medicinal product or for the period of follow-up of a medicinal product with which it is compared. https://monikasliupiene.lt/ koučingas, psichologas Vilniuje ir online, psichologija, lyderystės mokymas ir ugdymas